Italia markets close in 3 hours 22 minutes

JNJ Mar 2025 135.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
3,35000,0000 (0,00%)
In data: 12:28PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente3,3500
Aperto3,3500
Denaro0,0000
Domanda0,0000
Prezzo d'esercizio135,00
Scadenza2025-03-21
Min-Max giorno3,3500 - 3,3500
Contratto - Min-MaxN/D
Volume2
Open Interest419
  • GlobeNewswire

    Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

    According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA